The success of Sildenafil initially sparked a period of growth for the drug industry, nevertheless recent shifts present a murky outlook for shareholders. Lower-cost competitors are reducing revenue, and continued https://isaiahxeex478103.buyoutblog.com/41222267/viagra-and-big-pharma-a-risky-bet